Skip Navigation

HIV/AIDS

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Clinical Research

NIAID supports six clinical trial networks that conduct domestic and international human studies focused on the Institute’s highest HIV/AIDS research priorities including

  • New HIV prevention methods
  • Vaccine research and development
  • Microbicides to prevent HIV acquisition and transmission
  • Strategies to prevent mother-to-child HIV transmission
  • New drug development and optimizing clinical management of HIV/AIDS, including co-morbidities

The clinical trial networks include

Each network consists of a clinical trial unit led by a principal investigator and features an administrative component, community advisory board, and one or more clinical research sites, such as medical schools, academic health centers, hospitals, or outpatient centers, where the clinical trials are performed. For a complete listing of all of the clinical trial units and sites, see: HIV/AIDS Network Clinical Trials Units (CTU) and Clinical Research Sites (CRS).

Vaccine Research Center Studies

In addition to the six HIV/AIDS clinical trial networks, NIAID also conducts early stage HIV vaccine research through the Dale and Betty Bumpers Vaccine Research Center (VRC) on the National Institutes of Health campus in Bethesda, Maryland. The VRC Clinical Trials Core Laboratory performs Phase I human research of HIV vaccines developed at VRC.

For information about current federally funded and privately sponsored HIV/AIDS clinical trials, see AIDSinfo or ClinicalTrials.gov.

Epidemiological Research

NIAID supports investigator-initiated epidemiological research as well as a number of targeted programs and several large HIV/AIDS epidemiological cohort studies.

back to top

Last Updated September 14, 2010